Replicate Bioscience

Replicate Bioscience is using advanced srRNA technology, leveraging our proprietary synthetic immune lethality approach, to address life-threatening cancer drug resistance. We are also developing srRNA injections for sustained therapeutic protein expression to treat inflammatory diseases and other conditions. We believe srRNA will bring the next major breakthrough in RNA therapy and are working to fulfill the promise of srRNA for all patients.